UnitedHealth Group Incorporated (NYSE:UNH) Stake Boosted by Ensign Peak Advisors Inc

Ensign Peak Advisors Inc raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.8% during the second quarter, according to its most recent filing with the SEC. The firm owned 1,685,447 shares of the healthcare conglomerate’s stock after purchasing an additional 45,481 shares during the period. UnitedHealth Group accounts for about 1.6% of Ensign Peak Advisors Inc’s portfolio, making the stock its 7th largest position. Ensign Peak Advisors Inc owned 0.18% of UnitedHealth Group worth $858,331,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Aveo Capital Partners LLC increased its position in shares of UnitedHealth Group by 23.8% during the fourth quarter. Aveo Capital Partners LLC now owns 2,164 shares of the healthcare conglomerate’s stock worth $1,139,000 after purchasing an additional 416 shares in the last quarter. 9258 Wealth Management LLC grew its holdings in shares of UnitedHealth Group by 7.3% during the fourth quarter. 9258 Wealth Management LLC now owns 4,273 shares of the healthcare conglomerate’s stock valued at $2,250,000 after buying an additional 290 shares during the last quarter. Gryphon Financial Partners LLC lifted its position in UnitedHealth Group by 80.9% during the 4th quarter. Gryphon Financial Partners LLC now owns 6,220 shares of the healthcare conglomerate’s stock worth $3,275,000 after acquiring an additional 2,782 shares during the period. TrinityPoint Wealth LLC increased its holdings in shares of UnitedHealth Group by 102.8% in the fourth quarter. TrinityPoint Wealth LLC now owns 14,774 shares of the healthcare conglomerate’s stock valued at $7,778,000 after purchasing an additional 7,489 shares during the period. Finally, Orion Portfolio Solutions LLC boosted its position in UnitedHealth Group by 0.5% in the fourth quarter. Orion Portfolio Solutions LLC now owns 91,725 shares of the healthcare conglomerate’s stock valued at $49,213,000 after buying an additional 462 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

Insider Buying and Selling at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the sale, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The disclosure for this sale can be found here. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Down 0.4 %

Shares of NYSE UNH opened at $575.00 on Friday. The stock has a market cap of $529.22 billion, a PE ratio of 35.15, a P/E/G ratio of 1.64 and a beta of 0.58. The company has a 50-day moving average of $577.10 and a 200 day moving average of $520.47. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $607.94. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm had revenue of $98.86 billion for the quarter, compared to analysts’ expectations of $98.73 billion. During the same quarter in the previous year, the company posted $6.14 EPS. The company’s revenue was up 6.4% compared to the same quarter last year. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Investors of record on Monday, September 16th will be issued a $2.10 dividend. The ex-dividend date is Monday, September 16th. This represents a $8.40 annualized dividend and a yield of 1.46%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 51.34%.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of research reports. Royal Bank of Canada increased their price objective on shares of UnitedHealth Group from $555.00 to $615.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 17th. Robert W. Baird upped their target price on UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 17th. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Tuesday. Wells Fargo & Company boosted their target price on shares of UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. Finally, Argus increased their target price on shares of UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. One equities research analyst has rated the stock with a hold rating, nineteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Buy” and a consensus target price of $614.17.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.